{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:04:22Z","timestamp":1785863062078,"version":"3.56.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s43440-026-00871-5","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:55:05Z","timestamp":1781247305000},"page":"1045-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AMPA receptor modulation in depression: from molecular mechanisms of plasticity to therapeutic translation"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-3926","authenticated-orcid":false,"given":"Wojciech","family":"Ziemich\u00f3d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1781-6773","authenticated-orcid":false,"given":"Natalia","family":"Kajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2058-5395","authenticated-orcid":false,"given":"Klaudia","family":"Kister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7386-700X","authenticated-orcid":false,"given":"Karolina","family":"Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1493-8502","authenticated-orcid":false,"given":"Kaja","family":"Karaku\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2027-5469","authenticated-orcid":false,"given":"Dariusz","family":"Juchnowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"1","key":"871_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41398-023-02514-2","volume":"13","author":"AJ Cutler","year":"2023","unstructured":"Cutler AJ, Mattingly GW, Maletic V. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Transl Psychiatry. 2023;13(1):228.","journal-title":"Transl Psychiatry"},{"issue":"10328","key":"871_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)02141-3","volume":"399","author":"H Herrman","year":"2022","unstructured":"Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P, et al. Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022;399(10328):957\u20131022.","journal-title":"Lancet"},{"key":"871_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Association. Washington (DC): American Psychiatric Publishing; 2022."},{"issue":"10","key":"871_CR4","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1097\/MS9.0000000000002487","volume":"86","author":"X Wei","year":"2024","unstructured":"Wei X. The glutamatergic system in the development of stress-induced depression. Ann Med Surg. 2024;86(10):5930\u20137.","journal-title":"Ann Med Surg"},{"key":"871_CR5","first-page":"139","volume":"47","author":"K Schlossberg","year":"2010","unstructured":"Schlossberg K, Massler A, Zalsman G. Environmental risk factors for psychopathology. Isr J Psychiatry Relat Sci. 2010;47:139\u201343.","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev.psych.48.1.191","volume":"48","author":"RC Kessler","year":"1997","unstructured":"Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997;48:191\u2013214.","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"871_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-024-01738-y","volume":"9","author":"L Cui","year":"2024","unstructured":"Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, Wang Y, Tang Y, Xia M, Li B. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target therapy. 2024;9(1):30.","journal-title":"Signal Transduct Target therapy"},{"key":"871_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1055\/s-2007-979535","volume":"29","author":"GR Heninger","year":"1996","unstructured":"Heninger GR, Delgado PL, Charney DS. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. 1996;29:2\u201311.","journal-title":"Pharmacopsychiatry"},{"key":"871_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbr.2017.12.025","volume":"341","author":"E Jesulola","year":"2018","unstructured":"Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model \u2013 are we there yet? Behav Brain Res. 2018;341:79\u201390.","journal-title":"Behav Brain Res"},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.apha.2014.11.003","volume":"73","author":"B Luscher","year":"2015","unstructured":"Luscher B, Fuchs T. GABAergic control of depression-related brain states. Adv Pharmacol. 2015;73:97\u2013144.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"871_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","volume":"62","author":"G Sanacora","year":"2012","unstructured":"Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63\u201377.","journal-title":"Neuropharmacology"},{"issue":"11","key":"871_CR12","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/ph16111572","volume":"16","author":"CM Vecera","year":"2023","unstructured":"Vecera CM, Courtes AC, Jones G, Soares JC, Machado-Vieira R. Pharmacotherapies targeting GABA-glutamate neurotransmission for treatment-resistant depression. Pharmaceuticals (Basel). 2023;16(11):1572.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"871_CR13","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuron.2016.06.033","volume":"91","author":"R Tremblay","year":"2016","unstructured":"Tremblay R, Lee S, Rudy B. GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits. Neuron. 2016;91(2):260\u201392. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.033.","journal-title":"Neuron"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tins.2004.07.002","volume":"27","author":"I Mody","year":"2004","unstructured":"Mody I, Pearce RA. Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci. 2004;27:569\u201375.","journal-title":"Trends Neurosci"},{"issue":"2","key":"871_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/futurepharmacol5020027","volume":"5","author":"DP Radin","year":"2025","unstructured":"Radin DP, Cerne R, Smith JL, Witkin JM, Lippa A. Recovery from AMPA Receptor Potentiation by Ampakines. Future Pharmacol. 2025;5(2):27.","journal-title":"Future Pharmacol"},{"key":"871_CR16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/brainsci12101329","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, Bian L, Yin Y, Guo J. Targeting NMDA receptors in emotional disorders: their role in neuroprotection. Brain Sci. 2022;12:1329.","journal-title":"Brain Sci"},{"issue":"2","key":"871_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuron.2011.09.027","volume":"72","author":"JS Isaacson","year":"2011","unstructured":"Isaacson JS, Scanziani M. How inhibition shapes cortical activity. Neuron. 2011;72(2):231\u201343.","journal-title":"Neuron"},{"key":"871_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnmol.2012.00034","volume":"5","author":"A Wright","year":"2012","unstructured":"Wright A, Vissel B. The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain. Front Mol Neurosci. 2012;5:34.","journal-title":"Front Mol Neurosci"},{"issue":"8038","key":"871_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-024-08027-2","volume":"635","author":"I Hong","year":"2024","unstructured":"Hong I, Kim J, Hainmueller T, Kim DW, Keijser J, Johnson RC, Park SH, Limjunyawong N, Yang Z, Cheon D, Hwang T, Agarwal A, Cholvin T, Krienen FM, McCarroll SA, Dong X, Leopold DA, Blackshaw S, Sprekeler H, Bergles DE, Huganir RL. Calcium-permeable AMPA receptors govern PV neuron feature selectivity. Nature. 2024;635(8038):398\u2013405.","journal-title":"Nature"},{"issue":"10","key":"871_CR20","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1113\/JP279029","volume":"599","author":"SG Cull-Candy","year":"2021","unstructured":"Cull-Candy SG, Farrant M. Ca2+ -permeable AMPA receptors and their auxiliary subunits in synaptic plasticity and disease. J Physiol. 2021;599(10):2655\u201371.","journal-title":"J Physiol"},{"key":"871_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnsyn.2018.00034","volume":"10","author":"T Lalanne","year":"2018","unstructured":"Lalanne T, Oyrer J, Farrant M, Sj\u00f6str\u00f6m PJ. Synapse Type-Dependent Expression of Calcium-Permeable AMPA Receptors. Front Synaptic Neurosci. 2018;10:34.","journal-title":"Front Synaptic Neurosci"},{"issue":"1","key":"871_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10571-024-01529-7","volume":"45","author":"CAM de Le\u00f3n-L\u00f3pez","year":"2025","unstructured":"de Le\u00f3n-L\u00f3pez CAM, Carretero-Rey M, Khan ZU. AMPA Receptors in Synaptic Plasticity, Memory Function, and Brain Diseases. Cell Mol Neurobiol. 2025;45(1):14.","journal-title":"Cell Mol Neurobiol"},{"key":"871_CR23","doi-asserted-by":"publisher","first-page":"916626","DOI":"10.3389\/fncel.2022.916626","volume":"16","author":"DN Chiu","year":"2022","unstructured":"Chiu DN, Carter BC. Synaptic NMDA receptor activity at resting membrane potentials. Front Cell Neurosci. 2022;16:916626.","journal-title":"Front Cell Neurosci"},{"key":"871_CR24","doi-asserted-by":"publisher","unstructured":"Guirguis V, Korsapathy S, Pupillo F, McClure RK, Zarzar D, Zhang M, et al. Esketamine disinhibits brain networks in depression: evidence from oscillatory and aperiodic activity. Prog Neuropsychopharmacol Biol Psychiatry. 2025;140:111438. https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111438.","DOI":"10.1016\/j.pnpbp.2025.111438"},{"key":"871_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fncel.2019.00087","volume":"13","author":"MV Foga\u00e7a","year":"2019","unstructured":"Foga\u00e7a MV, Duman RS. Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions. Front Cell Neurosci. 2019;13:87.","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"871_CR26","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","volume":"24","author":"S Moriguchi","year":"2019","unstructured":"Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24(7):952\u201364.","journal-title":"Mol Psychiatry"},{"key":"871_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. Published 2019 Mar 26.","journal-title":"Res Integr Peer Rev"},{"issue":"8","key":"871_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.neurom.2021.09.003","volume":"25","author":"JC Brown","year":"2022","unstructured":"Brown JC, Higgins ES, George MS. Synaptic plasticity 101: the story of the AMPA receptor for the brain stimulation practitioner. Neuromodulation. 2022;25(8):1289\u201398.","journal-title":"Neuromodulation"},{"issue":"2","key":"871_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuron.2018.10.018","volume":"100","author":"GH Diering","year":"2018","unstructured":"Diering GH, Huganir RL. The AMPA Receptor Code of Synaptic Plasticity. Neuron. 2018;100(2):314\u201329.","journal-title":"Neuron"},{"issue":"3","key":"871_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med. 2016;22(3):238\u201349.","journal-title":"Nat Med"},{"key":"871_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.neubiorev.2015.03.005","volume":"52","author":"F Freudenberg","year":"2015","unstructured":"Freudenberg F, Celikel T, Reif A. The role of \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity? Neurosci Biobehav Rev. 2015;52:193\u2013206.","journal-title":"Neurosci Biobehav Rev"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","volume":"6","author":"P Willner","year":"2016","unstructured":"Willner P. The chroni\u0107 mild stress (CMS) model of depression: History, evaluation and usage. Neurobiol stress. 2016;6:78\u201393.","journal-title":"Neurobiol stress"},{"key":"871_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fnmol.2017.00244","volume":"10","author":"A Pacheco","year":"2017","unstructured":"Pacheco A, Aguayo FI, Aliaga E, et al. Chronic Stress Triggers Expression of Immediate Early Genes and Differentially Affects the Expression of AMPA and NMDA Subunits in Dorsal and Ventral Hippocampus of Rats. Front Mol Neurosci. 2017;10:244.","journal-title":"Front Mol Neurosci"},{"issue":"5994","key":"871_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010;329(5994):959\u201364.","journal-title":"Science"},{"issue":"5","key":"871_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.biopsych.2006.10.006","volume":"62","author":"C Normann","year":"2007","unstructured":"Normann C, Schmitz D, F\u00fcrmaier A, D\u00f6ing C, Bach M. Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry. 2007;62(5):373\u201380.","journal-title":"Biol Psychiatry"},{"issue":"12","key":"871_CR36","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","volume":"59","author":"RS Duman","year":"2006","unstructured":"Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116\u201327.","journal-title":"Biol Psychiatry"},{"issue":"Part C","key":"871_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuropharm.2013.04.005","volume":"76","author":"GD Leal","year":"2014","unstructured":"Leal GD, Comprido D, Duarte CB. BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology. 2014;76(Part C):639\u201356.","journal-title":"Neuropharmacology"},{"issue":"1","key":"871_CR38","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/s41598-023-29792-6","volume":"13","author":"MA Jog","year":"2023","unstructured":"Jog MA, Anderson C, Kubicki A, Boucher M, Leaver A, Hellemann G, Iacoboni M, Woods R, Narr K. Transcranial direct current stimulation (tDCS) in depression induces structural plasticity. Sci Rep. 2023;13(1):2841. https:\/\/doi.org\/10.1038\/s41598-023-29792-6.","journal-title":"Sci Rep"},{"key":"871_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fncel.2020.00082","volume":"14","author":"T Yang","year":"2020","unstructured":"Yang T, Nie Z, Shu H, Kuang Y, Chen X, Cheng J, Yu S, Liu H. The Role of BDNF on Neural Plasticity in Depression. Front Cell Neurosci. 2020;14:82. https:\/\/doi.org\/10.3389\/fncel.2020.00082.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"871_CR40","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41467-019-09562-7","volume":"10","author":"SE Holmes","year":"2019","unstructured":"Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019;10(1):1529.","journal-title":"Nat Commun"},{"issue":"7","key":"871_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1176\/appi.ajp.2011.09111607","volume":"168","author":"A Deschwanden","year":"2011","unstructured":"Deschwanden A, Karolewicz B, Feyissa AM, Treyer V, Ametamey SM, Johayem A, Burger C, Auberson YP, Sovago J, Stockmeier CA, Buck A, Hasler G. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study. Am J Psychiatry. 2011;168(7):727\u201334.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"871_CR42","first-page":"449","volume":"2","author":"CG Abdallah","year":"2017","unstructured":"Abdallah CG, Hannestad J, Mason GF, Holmes SE, DellaGioia N, Sanacora G, Jiang L, Matuskey D, Satodiya R, Gasparini F, Lin X, Javitch J, Planeta B, Nabulsi N, Carson RE, Esterlis I. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(5):449\u201356.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"5","key":"871_CR43","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1097\/ALN.0000000000000351","volume":"121","author":"AM Le","year":"2014","unstructured":"Le AM, Lee M, Su C, Zou A, Wang J. AMPAkines have novel analgesic properties in rat models of persistent neuropathic and inflammatory pain. Anesthesiology. 2014;121(5):1080\u201390.","journal-title":"Anesthesiology"},{"issue":"9","key":"871_CR44","first-page":"1181","volume":"2","author":"G Lynch","year":"2011","unstructured":"Lynch G, et al. Cognitive enhancement by drugs that target AMPA receptors. Curr Opin Investig Drugs. 2011;2(9):1181\u20136.","journal-title":"Curr Opin Investig Drugs"},{"issue":"5","key":"871_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/138945007780618490","volume":"8","author":"AC Arai","year":"2007","unstructured":"Arai AC, Kessler M. Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. Curr Drug Targets. 2007;8(5):583\u2013602.","journal-title":"Curr Drug Targets"},{"issue":"5","key":"871_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/ph15050646","volume":"15","author":"D Giordano","year":"2022","unstructured":"Giordano D, Biancaniello C, Argenio MA, Facchiano A. Drug design by pharmacophore and virtual screening approach. Pharmaceuticals (Basel). 2022;15(5):646.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"871_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.mencom.2017.11.029","volume":"27","author":"EV Radchenko","year":"2017","unstructured":"Radchenko EV, Karlov DS, Lavrov MI, Palyulin VA. Structural requirements for molecular design of positive allosteric modulators of AMPA receptor. Mendeleev Commun. 2017;27(6):343\u20139.","journal-title":"Mendeleev Commun"},{"issue":"12","key":"871_CR48","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.3390\/ijms241210293","volume":"24","author":"EA Golubeva","year":"2023","unstructured":"Golubeva EA, Lavrov MI, Veremeeva PN, Vyunova TV, Shevchenko KV, Topchiy MA, Asachenko AF, Palyulin VA. New Allosteric Modulators of AMPA Receptors: Synthesis and Study of Their Functional Activity by Radioligand-Receptor Binding Analysis. Int J Mol Sci. 2023;24(12):10293.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"871_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/neuroglia5030023","volume":"5","author":"DP Radin","year":"2024","unstructured":"Radin DP, Cerne R, Witkin J, Lippa A. High-Impact AMPAkines Elevate Calcium Levels in Cortical Astrocytes by Mobilizing Endoplasmic Reticular Calcium Stores. Neuroglia. 2024;5(3):344\u201355.","journal-title":"Neuroglia"},{"issue":"3","key":"871_CR50","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","volume":"25","author":"RB Price","year":"2020","unstructured":"Price RB, Duman R. Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model. Mol Psychiatry. 2020;25(3):530\u201343.","journal-title":"Mol Psychiatry"},{"issue":"39","key":"871_CR51","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1523\/JNEUROSCI.2567-05.2005","volume":"25","author":"R Jin","year":"2005","unstructured":"Jin R, Clark S, Weeks AM, Dudman JT, Gouaux E, Partin KM. Mechanism of positive allosteric modulators acting on AMPA receptors. J Neurosci. 2005;25(39):9027\u201336.","journal-title":"J Neurosci"},{"issue":"1","key":"871_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuroscience.2008.12.018","volume":"159","author":"JC Lauterborn","year":"2009","unstructured":"Lauterborn JC, Pineda E, Chen LY, Ramirez EA, Lynch G, Gall CM. Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression. Neuroscience. 2009;159(1):283\u201395.","journal-title":"Neuroscience"},{"issue":"1","key":"871_CR53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","volume":"20","author":"JC Lauterborn","year":"2000","unstructured":"Lauterborn JC, Lynch G, Vanderklish P, Arai A, Gall CM. Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci. 2000;20(1):8\u201321.","journal-title":"J Neurosci"},{"key":"871_CR54","doi-asserted-by":"crossref","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA, Jr, Gould TD. (2016). NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Natur. 533(7604):481\u2013486.","DOI":"10.1038\/nature17998"},{"key":"871_CR55","doi-asserted-by":"publisher","first-page":"115924","DOI":"10.1016\/j.taap.2022.115924","volume":"439","author":"H Yao","year":"2022","unstructured":"Yao H, Zhang D, Yu H, Shen H, Lan X, Liu H, Chen X, Wu X, Zhang G, Wang X. AMPAkine CX516 alleviated chronic ethanol exposure-induced neurodegeneration and depressive-like behavior in mice. Toxicol Appl Pharmacol. 2022;439:115924.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"871_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-2999(02)01338-9","volume":"440","author":"RJ Knapp","year":"2002","unstructured":"Knapp RJ, Goldenberg R, Shuck C, Cecil A, Watkins J, Miller C, Crites G, Malatynska E. Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. Eur J Pharmacol. 2002;440(1):27\u201335.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"871_CR57","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.drudis.2021.07.027","volume":"26","author":"B Kadriu","year":"2021","unstructured":"Kadriu B, Musazzi L, Johnston JN, Kalynchuk LE, Caruncho HJ, Popoli M, Zarate CA Jr. Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road. Drug Discov Today. 2021;26(12):2816\u201338.","journal-title":"Drug Discov Today"},{"issue":"1\u20133","key":"871_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00213-008-1325-2","volume":"202","author":"ML Woolley","year":"2009","unstructured":"Woolley ML, Waters KA, Gartlon JE, Lacroix LP, Jennings C, Shaughnessy F, et al. Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. Psychopharmacology. 2009;202(1\u20133):343\u201354.","journal-title":"Psychopharmacology"},{"key":"871_CR59","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.biopha.2018.06.008","volume":"105","author":"DP Radin","year":"2018","unstructured":"Radin DP, Johnson S, Purcell R, Lippa AS. Effects of chronic systemic low-impact ampakine treatment on neurotrophin expression in rat brain. Biomed Pharmacother. 2018;105:540\u20134.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"871_CR60","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1007\/s12035-020-01954-x","volume":"57","author":"M Gordillo-Salas","year":"2020","unstructured":"Gordillo-Salas M, Pascual-Ant\u00f3n R, Ren J, Greer J, Adell A. Antidepressant-Like Effects of CX717, a Positive Allosteric Modulator of AMPA Receptors. Mol Neurobiol. 2020;57(8):3498\u2013507.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"871_CR61","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.tins.2006.07.007","volume":"29","author":"G Lynch","year":"2006","unstructured":"Lynch G, Gall CM. Ampakines and the threefold path to cognitive enhancement. Trends Neurosci. 2006;29(10):554\u201362.","journal-title":"Trends Neurosci"},{"issue":"9","key":"871_CR62","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1017\/S1461145709991076","volume":"13","author":"S Farley","year":"2010","unstructured":"Farley S, Apazoglou K, Witkin JM, Giros B, Tzavara ET. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol. 2010;13(9):1207\u201318.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"8","key":"871_CR63","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0028-3908(00)00194-5","volume":"40","author":"X Li","year":"2001","unstructured":"Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P. Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology. 2001;40(8):1028\u201333.","journal-title":"Neuropharmacology"},{"issue":"2","key":"871_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00213-009-1598-0","volume":"206","author":"XW Su","year":"2009","unstructured":"Su XW, Li XY, Banasr M, Koo JW, Shahid M, Henry B, Duman RS. Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus. Psychopharmacology. 2009;206(2):215\u201322.","journal-title":"Psychopharmacology"},{"issue":"7","key":"871_CR65","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/FBP.0b013e328331ba1b","volume":"20","author":"E Hamlyn","year":"2009","unstructured":"Hamlyn E, Brand L, Shahid M, Harvey BH. The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats. Behav Pharmacol. 2009;20(7):662\u20137.","journal-title":"Behav Pharmacol"},{"issue":"2","key":"871_CR66","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.phrs.2011.10.004","volume":"65","author":"F Fumagalli","year":"2012","unstructured":"Fumagalli F, Calabrese F, Luoni A, Shahid M, Racagni G, Riva MA. The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus. Pharmacol Res. 2012;65(2):176\u201381.","journal-title":"Pharmacol Res"},{"key":"871_CR67","doi-asserted-by":"publisher","first-page":"173289","DOI":"10.1016\/j.pbb.2021.173289","volume":"211","author":"H Hara","year":"2021","unstructured":"Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats. Pharmacol Biochem Behav. 2021;211:173289.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"871_CR68","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/biomedicines13061389","volume":"13","author":"L Li","year":"2025","unstructured":"Li L, Zhang Z, Liu X, Zhou M, Wen S, Dai J. TAK-653 Reverses Core Depressive Symptoms in Chronic Stress-Induced Monkey Model. Biomedicines. 2025;13(6):1389.","journal-title":"Biomedicines"},{"issue":"12","key":"871_CR69","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1177\/0269881112458728","volume":"26","author":"KR Nations","year":"2012","unstructured":"Nations KR, Dogterom P, Bursi R, Schipper J, Greenwald S, Zraket D, Gertsik L, Johnstone J, Lee A, Pande Y, Ruigt G, Ereshefsky L. Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 2012;26(12):1525\u201339.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"871_CR70","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2165\/11634360-000000000-00000","volume":"12","author":"KR Nations","year":"2012","unstructured":"Nations KR, Bursi R, Dogterom P, Ereshefsky L, Gertsik L, Mant T, Schipper J. Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection. Drugs R D. 2012;12(3):127\u201339.","journal-title":"Drugs R D"},{"issue":"1","key":"871_CR71","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41398-022-02148-w","volume":"12","author":"F Dijkstra","year":"2022","unstructured":"Dijkstra F, O\u2019Donnell P, Klaassen E, Buhl D, Asgharnejad M, Rosen L, Zuiker R, van Gerven J, Jacobs G. Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers. Transl Psychiatry. 2022;12(1):408.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"871_CR72","doi-asserted-by":"publisher","first-page":"e13791","DOI":"10.1111\/cts.13791","volume":"17","author":"S Lin","year":"2024","unstructured":"Lin S, Ionescu A, Maynard-Scott J, Kennedy M, Walling DP, Furey M, Singh JB. Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults. Clin Transl Sci. 2024;17(5):e13791.","journal-title":"Clin Transl Sci"},{"issue":"D1","key":"871_CR73","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2025 update. Nucleic Acids Res. 2025;53(D1):D1516\u201325. https:\/\/doi.org\/10.1093\/nar\/gkae1059.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"871_CR74","first-page":"265","volume":"38","author":"DP Radin","year":"2018","unstructured":"Radin DP, Purcell R, Lippa AS. Oncolytic Properties of Ampakines In Vitro. Anticancer Res. 2018;38(1):265\u20139.","journal-title":"Anticancer Res"},{"issue":"4","key":"871_CR75","doi-asserted-by":"publisher","first-page":"e94255","DOI":"10.1371\/journal.pone.0094255","volume":"9","author":"J Tucholski","year":"2014","unstructured":"Tucholski J, Pinner AL, Simmons MS, Meador-Woodruff JH. Evolutionarily conserved pattern of AMPA receptor subunit glycosylation in mammalian frontal cortex. PLoS ONE. 2014;9(4):e94255.","journal-title":"PLoS ONE"},{"issue":"2","key":"871_CR76","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/ijms19020580","volume":"19","author":"IG Ferreira","year":"2018","unstructured":"Ferreira IG, Pucci M, Venturi G, Malagolini N, Chiricolo M, Dall\u2019Olio F. Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling. Int J Mol Sci. 2018;19(2):580.","journal-title":"Int J Mol Sci"},{"key":"871_CR77","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1007\/s12035-022-03053-5","volume":"59","author":"EW Westi","year":"2022","unstructured":"Westi EW, Jakobsen E, Voss CM, Hansen SH, Waagepetersen HS. Divergent cellular energetics, glutamate metabolism, and mitochondrial function between human and mouse cerebral cortex. Mol Neurobiol. 2022;59:7495\u2013512.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"871_CR78","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci. 2010;13(10):1161\u20139.","journal-title":"Nat Neurosci"},{"issue":"1","key":"871_CR79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/diagnostics11010123","volume":"11","author":"M Becker","year":"2021","unstructured":"Becker M, Pinhasov A, Ornoy A. Animal models of depression: what can they teach us about the human disease? Diagnostics (Basel). 2021;11(1):123.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"871_CR80","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12967-018-1678-1","volume":"16","author":"P Pound","year":"2018","unstructured":"Pound P, Ritskes-Hoitinga M. Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail. J Transl Med. 2018;16(1):304.","journal-title":"J Transl Med"},{"issue":"19","key":"871_CR81","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s00213-015-4034-7","volume":"232","author":"P Willner","year":"2015","unstructured":"Willner P, Belzung C. Treatment-resistant depression: are animal models of depression fit for purpose? Psychopharmacology. 2015;232(19):3473\u201395.","journal-title":"Psychopharmacology"},{"key":"871_CR82","doi-asserted-by":"publisher","first-page":"1054887","DOI":"10.3389\/fpsyt.2022.1054887","volume":"13","author":"R Guglielmo","year":"2022","unstructured":"Guglielmo R, de Filippis R, Ouanes S, Hasler G. Editorial: The glutamate hypothesis of mood disorders: Neuroplasticity processes, clinical features, treatment perspectives. Front Psychiatry. 2022;13:1054887.","journal-title":"Front Psychiatry"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00871-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00871-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00871-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:03:24Z","timestamp":1785859404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00871-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00871-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used an AI-based language model (ChatGPT, Open AI) to assist with language editing and content structuring. All generated content was reviewed and approved by the authors, who take full responsibility for the scientific accuracy and integrity of the manuscript.","order":2,"name":"Ethics","label":"Declaration of AI use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}